Discover Thomson Reuters
The pharmaceutical giant said it was already accessing many of the potential benefits of a split. But as Fred Katayama reports, taxes may be the reason behind its decision.
01:16
02:10
01:45
07:21
01:58
01:29
02:07
01:53
02:09
01:49
01:05
00:37
01:10
01:46
01:13
01:37
01:36
01:42
01:57